TABLE 1.
Pretest EORTC category | No. of: |
No. (%) positive by: |
Culture vs PCR P valueb | |||
---|---|---|---|---|---|---|
Unique patientsa | Patients with pretest antifungal exposure | Paired specimens | Culture | PCR | ||
All | 52 | 43 | 54 | 29 (53.7) | 36 (66.7) | 0.238 |
Proven IFI | 28 | 23 | 28 | 22 (78.6) | 25 (89.3) | 0.844 |
Probable IFI | 9 | 7 | 10 | 5 (50.0) | 7 (70.0) | 0.726 |
Possible IFI | 11 | 11 | 11 | 0 (0.0) | 1 (9.1) | NDd |
Not applicablec | 5 | 1 | 5 | 2 (40.0) | 3 (60.0) | ND |
One patient had parallel PCR and culture performed three times with >3 weeks between each sampling, and each encounter was included as a single unique patient for overall counts, but testing was counted twice as “probable” and once as “proven” IFI based on chart review.
Fisher’s exact test.
One patient to whom EORTC criteria were not applicable had HIV and a CD4 count of 14 cells/μl, and pretest amphotericin B had a true positive detection of A. fumigatus by PCR only; all other results for patients in this category were clinically thought to reflect bystanders/colonizers.
ND, not determined.